Protalix Share Price

Protalix Share Price

AMEX: PLX | Micro Cap | Healthcare
$3.00
+$0.10 (3.62%) Last updated on 19 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Protalix Stock Performance

Open
$2.92
Prev. Close
$2.90
Circuit Range
N/A
Day Range
$2.90 - $3.01
Year Range
$1.65 - $3.19
Volume
59,480
Average Traded
$2.96

Protalix Share Price Today

As of 19 November 2026, Protalix BioTherapeutics, Inc.'s share price is $3.00. The stock opened at $2.92, compared to its previous close of $2.90. During today's trading session, Protalix BioTherapeutics, Inc.'s share price traded between $2.90 and $3.01, with an average price of $2.96. Over the past 52 weeks, the stock has recorded a high of $3.19 and a low of $1.65. In terms of performance, Protalix BioTherapeutics, Inc.'s share price has risen by 42.76% over the last six months and is up 67.88% on a year-on-year basis.

Protalix Share Price Chart

Line chart of the Protalix price trend over the selected period. The price rose overall, ranging from 2.89 to 3.00, ending at 3.00.
$2.90$3.01
L
Show Current Price
H

Protalix Stock Fundamentals & Key Indicators

Market Cap
$236.03M
PE Ratio (TTM)
11.82
Dividend Yield
0.00%
EPS (TTM)
$0.24
Revenue (TTM)
$52.74B
Return On Equity (TTM)
25.51%
Profit Margin
-12.51%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
172.00%

Protalix Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$9.12$33.75$19.90$21.93
Net Profit-$5.50$18.32$3.78$3.96
Net Profit Margin-60.31%54.28%18.99%18.06%
Income ChangeN/A433.09%-79.37%4.76%

Protalix Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$47.64$65.49$53.40$52.74
Net Profit-$14.93$8.31$2.93-$6.60
Net Profit Margin-31.34%12.69%5.49%-12.51%
Income ChangeN/A155.66%-64.74%-325.26%

Protalix Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets15.6713.3414.510.91
Current Assets66.6760.0869.9344.88
Total Assets82.3573.4284.4355.79
Non Current Liabilities7.64.595.3434.0
Current Liabilities26.5225.6245.5332.43
Total Liabilities34.1230.2150.8766.43
Shareholders' Equity48.2343.2133.57-10.64

Protalix Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-11.998.67-1.32-25.0
Investing-2.374.22-16.71-5.04
Financing9.33-16.7924.678.24

Corporate Actions

Split
Ex-date: 20 Dec 2019

About Protalix

Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.

Protalix Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$2.60
$3.00
+15.83%
Oct 2026
$2.73
$2.59
-5.82%
Sep 2026
$2.62
$2.75
+5.36%
Aug 2026
$2.45
$2.61
+9.66%
Jul 2026
$2.33
$2.38
+2.81%
Jun 2026
$2.10
$2.31
+9.98%
May 2026
$2.14
$2.10
-1.64%
Apr 2026
$2.21
$2.14
-2.28%
Mar 2026
$2.80
$2.19
-23.96%
Feb 2026
$2.35
$2.88
+24.14%
Jan 2026
$1.83
$2.32
+29.25%
Dec 2025
$1.77
$1.79
+0.28%

Protalix Share Price FAQs